61. Tofacitinib benefit‐risk profile in chronic plaque psoriasis. (1st January 2019) Authors: Strober, B.E.; Gottlieb, A.B.; van de Kerkhof, P.C.M.; Puig, L.; Bachelez, H.; Chouela, E.; Imafuku, S.; Thaçi, D.; Tan, H.; Valdez, H.; Gupta, P.; Kaur, M.; Frajzyngier, V.; Wolk, R. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Tofacitinib benefit‐risk profile in chronic plaque psoriasis. (2nd January 2019) Authors: Strober, B.E.; Gottlieb, A.B.; van de Kerkhof, P.C.M.; Puig, L.; Bachelez, H.; Chouela, E.; Imafuku, S.; Thaçi, D.; Tan, H.; Valdez, H.; Gupta, P.; Kaur, M.; Frajzyngier, V.; Wolk, R. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). (1st February 2014) Authors: Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M. Journal: British journal of dermatology Issue: Volume 170:Number 2(2014:Feb.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). (February 2014) Authors: Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M. Journal: British journal of dermatology Issue: Volume 170:Number 2(2014:Feb.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. (31st May 2018) Authors: Polivka, L.; Oubaya, N.; Bachelez, H.; Paul, C.; Richard, M.A.; Beylot‐Barry, M.; Schmutz, J.L.; Beneton, N.; Mahé, E.; Viguier, M.; Chosidow, O.; Canoui‐Poitrine, F.; Sbidian, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 11(2018) Page Start: 1920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak. (1st December 2021) Authors: Frumholtz, L.; Bouaziz, J.‐D.; Battistella, M.; Hadjadj, J.; Chocron, R.; Bengoufa, D.; Le Buanec, H.; Barnabei, L.; Meynier, S.; Schwartz, O.; Grzelak, L.; Smith, N.; Charbit, B.; Duffy, D.; Yatim, N.; Calugareanu, A.; Philippe, A.; Guerin, C.L.; Joly, B.; Siguret, V. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak. (5th October 2021) Authors: Frumholtz, L.; Bouaziz, J.‐D.; Battistella, M.; Hadjadj, J.; Chocron, R.; Bengoufa, D.; Le Buanec, H.; Barnabei, L.; Meynier, S.; Schwartz, O.; Grzelak, L.; Smith, N.; Charbit, B.; Duffy, D.; Yatim, N.; Calugareanu, A.; Philippe, A.; Guerin, C.L.; Joly, B.; Siguret, V. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Use of mind‐body practices by patients with psoriasis: results from a study on 2562 patients. (21st December 2020) Authors: Misery, L.; Shourick, J.; Sénéschal, J.; Paul, C.; de Pouvourville, G.; Jullien, D.; Mahé, E.; Bachelez, H.; Aubert, R.; Joly, P.; Héas, S.; Reguiai, Z.; Ezzedine, K.; Taieb, C.; Richard, M.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 4(2021) Page Start: e305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ. (17th October 2019) Authors: Masson Regnault, M.; Castañeda‐Sanabria, J.; Diep Tran, M.H.T.; Beylot‐Barry, M.; Bachelez, H.; Beneton, N.; Chosidow, O.; Dupuy, A.; Joly, P.; Jullien, D.; Mahé, E.; Richard, M.‐A.; Viguier, M.; Tubach, F.; Sbidian, E.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 2(2020) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. 托法替布在慢性斑块型银屑病中的获益风险特征. (1st January 2019) Authors: Strober, B.E.; Gottlieb, A.B.; van de Kerkhof, P.C.M.; Puig, L.; Bachelez, H.; Chouela, E.; Imafuku, S.; Thaçi, D.; Tan, H.; Valdez, H.; Gupta, P.; Kaur, M.; Frajzyngier, V.; Wolk, R. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗